National Cancer Institute

Map of Socialist Republic of Vietnam through magnifying glass
October 6, 2016

Vanderbilt scientists to lead chronic disease research initiative in Vietnam

Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.

By VUMC News and Communications
October 29, 2015

Investigators find clues to melanoma treatment resistance

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

By VUMC News and Communications
September 17, 2015

Strong scores put VICC among top NCI centers

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).

By VUMC News and Communications
August 13, 2015

Macara lands award to explore cancer cell behavior

Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.”

By Bill Snyder
April 2, 2015

NCI’s national report shows cancer deaths on decline in U.S.

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.

By VUMC News and Communications
March 26, 2015

Photo: Cancer discoveries

Louis Staudt, M.D., Ph.D., director of the National Cancer Institute (NCI) Center for Cancer Genomics and co-chief of the NCI’s Lymphoid Malignancies Branch, spoke about new lymphoma therapies at his recent Flexner Discovery Lecture.

By VUMC News and Communications
March 12, 2015

National Cancer Institute’s Staudt set for Discovery Lecture

Louis Staudt, M.D., Ph.D., a pioneer in gene expression profiling at the National Cancer Institute (NCI), will deliver the next Flexner Discovery Lecture on Thursday, March 19.
By Bill Snyder
November 14, 2013

National Cancer Institute director set for Discovery Lecture

The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall.
By Leigh MacMillan
February 28, 2013

Vaccination key to preventing HPV-related cancers

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.
By VUMC News and Communications
October 31, 2012

Green tea found to reduce rate of some GI cancers

Green tea may lower risk of some digestive cancers.
By VUMC News and Communications
September 29, 2011

Folate may lower breast cancer risk for some

Low folate levels may increase a premenopausal woman’s risk of developing breast cancer.
By VUMC News and Communications
June 24, 2011

Antioxidant genes keep stomach moving

Antioxidant genes may be good targets for treating a stomach disorder that affects up to 40 percent of patients with diabetes.
By Leigh MacMillan
April 12, 2011

Soy foods not a risk for breast cancer survivors

By VUMC News and Communications
1 2 3 4 5